IRM three-lens brief
Evidence-based stock research on IRM. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
IRM moved -0.08% overnight.
- P/E of 237 — priced for high growth; little margin of safety.
- Negative free cash flow last quarterly (-$1.17B).
IRM closed at $116.03 (-0.08%) as of 2026-04-25. Market cap: $34.52B. P/E (trailing) 236.8. Concerns: p/E of 237 — priced for high growth; little margin of safety.; negative free cash flow last quarterly (-$1.17B).. Last quarter: Revenue $1.84B, net income $89.27M, free cash flow -$1.17B.
Why three lenses on IRM, not one.
A single reasoning model has blind spots it doesn’t know about. We examine IRMacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/IRM" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath IRM brief"></iframe>